Beijing Northland Biotech. Co., Ltd. was established in June, 2004. Our main business is R&D of novel bio-medicines and the industrialization of ophthalmic products. We are listed on NEEQ (National Equities Exchange and Quotations, 430047) since 2009. We have been developing 7 novel bio-medicines and have acheived 11 patents. Beijing Northland has been qualified for China's national 11th, 12th, and 13th Five Year Development Plans and has earned the strong support from the government. In 2012, we established Beijing Huonland pharmaceutical co., Ltd., a joint venture of Beijing Northland(China) and Huons(Korea), aiming to be the Asia's biggest ophthalmic sterilized eye drop plant. We are currently on a project to build a bio-medicine manufacturing plant complex.